We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBCH
3301
Turtle Beach Corp
TBCH
$277M
$155K ﹤0.01%
+13,400
New +$142K
ADAM
3302
Adamas Trust
ADAM
$883M
$154K ﹤0.01%
6,220
+284
+5% +$7.01K
JVA icon
3303
Coffee Holding Co
JVA
$20M
$152K ﹤0.01%
37,150
+2,600
+8% +$12.5K
AFT
3304
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$152K ﹤0.01%
10,181
-3,706
-27% -$55.6K
MUH
3305
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
$152K ﹤0.01%
+10,080
New +$150K
MNTA
3306
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$152K ﹤0.01%
12,240
-1,000
-8% -$13.3K
TACO
3307
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$152K ﹤0.01%
+11,839
New +$130K
NHA
3308
DELISTED
Nuveen Municipal 2021 Target Term Fund
NHA
$150K ﹤0.01%
15,560
+1,060
+7% +$10.2K
BKD icon
3309
Brookdale Senior Living
BKD
$3.4B
$146K ﹤0.01%
20,200
-300
-1% -$1.98K
PFO
3310
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$119M
$146K ﹤0.01%
12,460
+1,000
+9% +$11.5K
VZ icon
3311
CALL
Verizon
VZ
$196B
$146K ﹤0.01%
237,700
+58,300
+32% +$3.36M
MUS
3312
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$146K ﹤0.01%
11,782
+1,068
+10% +$13K
NAN icon
3313
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$142K ﹤0.01%
10,245
NGD
3314
DELISTED
New Gold Inc
NGD
$142K ﹤0.01%
146,893
-6,665
-4% -$5.29K
FPH icon
3315
Five Point Holdings
FPH
$375M
$141K ﹤0.01%
18,709
+6,645
+55% +$52.8K
JCI icon
3316
CALL
Johnson Controls International
JCI
$92.2B
$141K ﹤0.01%
49,700
-1,300
-3% -$50K
AROC icon
3317
Archrock
AROC
$5.8B
$140K ﹤0.01%
13,183
-1,499
-10% -$14.7K
SNDX icon
3318
Syndax Pharmaceuticals
SNDX
$1.82B
$140K ﹤0.01%
15,000
-5,000
-25% -$36.4K
CEV
3319
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$139K ﹤0.01%
11,204
-8,815
-44% -$108K
SIGA icon
3320
SIGA Technologies
SIGA
$219M
$138K ﹤0.01%
24,300
+3,200
+15% +$17.7K
CCXI
3321
DELISTED
ChemoCentryx, Inc.
CCXI
$138K ﹤0.01%
14,824
+950
+7% +$11K
CSCO icon
3322
CALL
Cisco
CSCO
$479B
$137K ﹤0.01%
248,200
+45,000
+22% +$2.49M
ATRS
3323
DELISTED
Antares Pharma, Inc.
ATRS
$136K ﹤0.01%
41,416
+2,623
+7% +$7.59K
MFD
3324
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
$135K ﹤0.01%
13,031
+432
+3% +$4.65K
AGRO icon
3325
Adecoagro
AGRO
$1.36B
$134K ﹤0.01%
18,797
-2,745
-13% -$18.8K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.